<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_TOP_FUNCTIONAL_NETWORK_UP</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_TOP_FUNCTIONAL_NETWORK_UP
        </div>
        <div class="card-body">
                <p>OBJECTIVE: To dissect the biological mechanisms involved in the cellular responses to a candidate vaccine containing 5 HIV peptides coupled to a palmytoil tail (HIV-LIPO-5) in healthy volunteers, by using extensive immunogenicity assessments with different stimulation durations. DESIGN: Immunogenicity substudy of a randomized phase II prophylactic HIV vaccine trial (ANRS VAC 18). METHODS: HIV-LIPO-5 or placebo was administered at W0, W4, W12 and W24. Peripheral blood mononuclear cells from a subset of participants at W0 and W14 were stimulated with HIV-LIPO-5, Gag peptides contained in the vaccine and control peptides. ELISpot, lymphoproliferation, intracellular cytokine staining (ICS), cytokine multiplex and transcriptomic analyses were performed. Different time points and stimulation conditions were compared, controlling for test multiplicity. RESULTS: Cultured ELISpot and lymphoproliferation responses were detected at W14. Ex-vivo ICS showed mainly interleukin (IL)-2-producing cells. Secretion of interferon (IFN)-gamma, tumour necrosis factor (TNF)-alpha, IL-5 and IL-13 increased significantly after culture and Gag stimulation at W14 compared to W0. Metallothionein genes were consistently overexpressed after HIV-LIPO-5 stimulation at W0 and W14. At W14, significant probes increased substantially, including IFN-gamma, CXCL9, IL2RA, TNFAIP6, CCL3L1 and IL-6. Canonical pathway analyses indicated a role of interferon signalling genes in response to HIV-LIPO-5. CONCLUSION: HIV-LIPO-5 vaccination elicited Th1 and Th2 memory precursor responses and a consistent modulation in gene expression. The response profile before vaccination suggests an adjuvant effect of the lipid tail of HIV-LIPO-5. Our combined immunogenicity analyses allowed to identify a specific signature profile of HIV-LIPO-5 and indicate that HIV-LIPO-5 could be further developed as a prime in heterologous prime-boost strategies.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M41035">M41035</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:3601">ncbigene:3601</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:81793">ncbigene:81793</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7980">ncbigene:7980</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10537">ncbigene:10537</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6349">ncbigene:6349</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8784">ncbigene:8784</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5698">ncbigene:5698</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6891">ncbigene:6891</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6372">ncbigene:6372</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4283">ncbigene:4283</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6890">ncbigene:6890</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:56300">ncbigene:56300</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6346">ncbigene:6346</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3456">ncbigene:3456</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8651">ncbigene:8651</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6772">ncbigene:6772</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10148">ncbigene:10148</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:127933">ncbigene:127933</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3552">ncbigene:3552</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3458">ncbigene:3458</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2633">ncbigene:2633</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7293">ncbigene:7293</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:11009">ncbigene:11009</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3620">ncbigene:3620</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:969">ncbigene:969</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8767">ncbigene:8767</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8835">ncbigene:8835</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M41035&#39;, name=&#39;RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_TOP_FUNCTIONAL_NETWORK_UP&#39;), definition=&#39;OBJECTIVE: To dissect the biological mechanisms involved in the cellular responses to a candidate vaccine containing 5 HIV peptides coupled to a palmytoil tail (HIV-LIPO-5) in healthy volunteers, by using extensive immunogenicity assessments with different stimulation durations. DESIGN: Immunogenicity substudy of a randomized phase II prophylactic HIV vaccine trial (ANRS VAC 18). METHODS: HIV-LIPO-5 or placebo was administered at W0, W4, W12 and W24. Peripheral blood mononuclear cells from a subset of participants at W0 and W14 were stimulated with HIV-LIPO-5, Gag peptides contained in the vaccine and control peptides. ELISpot, lymphoproliferation, intracellular cytokine staining (ICS), cytokine multiplex and transcriptomic analyses were performed. Different time points and stimulation conditions were compared, controlling for test multiplicity. RESULTS: Cultured ELISpot and lymphoproliferation responses were detected at W14. Ex-vivo ICS showed mainly interleukin (IL)-2-producing cells. Secretion of interferon (IFN)-gamma, tumour necrosis factor (TNF)-alpha, IL-5 and IL-13 increased significantly after culture and Gag stimulation at W14 compared to W0. Metallothionein genes were consistently overexpressed after HIV-LIPO-5 stimulation at W0 and W14. At W14, significant probes increased substantially, including IFN-gamma, CXCL9, IL2RA, TNFAIP6, CCL3L1 and IL-6. Canonical pathway analyses indicated a role of interferon signalling genes in response to HIV-LIPO-5. CONCLUSION: HIV-LIPO-5 vaccination elicited Th1 and Th2 memory precursor responses and a consistent modulation in gene expression. The response profile before vaccination suggests an adjuvant effect of the lipid tail of HIV-LIPO-5. Our combined immunogenicity analyses allowed to identify a specific signature profile of HIV-LIPO-5 and indicate that HIV-LIPO-5 could be further developed as a prime in heterologous prime-boost strategies.&#39;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;23759749&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3601&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;81793&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7980&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10537&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6349&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8784&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5698&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6891&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6372&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4283&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6890&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;56300&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6346&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3456&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8651&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6772&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10148&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;127933&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3552&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3458&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2633&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7293&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;11009&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3620&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;969&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8767&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8835&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C7&#39;], &#39;sub_category_code&#39;: [&#39;VAX&#39;], &#39;contributor&#39;: [&#39;HIPC SIGNATURES&#39;], &#39;exact_source&#39;: [&#39;Suppl Fig 6&#39;], &#39;external_details_url&#39;: [&#39;http://links.lww.com/QAD/A314&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>